Frank A. D'Amelio Named CFO of Pfizer

Article

Frank A. D'Amelio has been named senior vice president and chief financial officer of Pfizer (New York, NY, www.pfizer.com), effective in mid-September.

Frank A. D’Amelio has been named senior vice president and chief financial officer of Pfizer (New York, NY, www.pfizer.com), effective in mid-September. D’Amelio has almost three decades of operating and financial experience at AT&T, Lucent Technologies, and Alcatel-Lucent, having served as both chief operating officer and chief financial officer at Lucent.

He succeeds Alan Levin, whose resignation from Pfizer was announced in May.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Mike Schaefers Simtra BioPharma Solutions, Shiva Khalafpour MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany
Chris Hagen, SCIEX
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.